Omaveloxolone

Major

Omaveloxolone Acetaminophen And Codeine Capital® & Codeine Explained Reduced codeine and morphine exposure, reduced opioid efficacy and precipitation of opioid withdrawal Details Omaveloxolone Clindamycin ANTIROBE Explained Reduced CYP3A4 substrate exposure and reduced efficacy of CYP3A4 substrate Details Omaveloxolone Omeprazole Gastrobim Explained Reduced CYP3A4 substrate exposure and reduced efficacy of CYP3A4 substrate Details Omaveloxolone Sertraline Explained Reduced CYP3A4 substrate exposure and reduced efficacy of CYP3A4 substrate Details Omaveloxolone Buprenorphine Belbuca Explained Reduced CYP3A4 substrate exposure and reduced efficacy of CYP3A4 substrate Details Omaveloxolone Colchicine Colcrys Explained Reduced CYP3A4 substrate exposure and reduced efficacy of CYP3A4 substrate Details Omaveloxolone Simvastatin Flolipid Explained Reduced CYP3A4 substrate exposure and reduced efficacy of CYP3A4 substrate Details Omaveloxolone Abemaciclib Verzenio Explained Reduced CYP3A4 substrate exposure and reduced efficacy of CYP3A4 substrate Details Omaveloxolone Acalabrutinib Calquence Reduced CYP3A4 substrate exposure and reduced efficacy of CYP3A4 substrate Details Omaveloxolone Alpelisib Piqray Reduced CYP3A4 substrate exposure and reduced efficacy of CYP3A4 substrate Details Omaveloxolone Apixaban Eliquis Explained Reduced CYP3A4 substrate exposure and reduced efficacy of CYP3A4 substrate Details Omaveloxolone Apremilast Otezla Reduced CYP3A4 substrate exposure and reduced efficacy of CYP3A4 substrate Details Omaveloxolone Aripiprazole Injection Abilify Reduced CYP3A4 substrate exposure and reduced efficacy of CYP3A4 substrate Details Omaveloxolone Asciminib Scemblix Reduced CYP3A4 substrate exposure and reduced efficacy of CYP3A4 substrate Details Omaveloxolone Atogepant Qulipta Reduced atogepant exposure Details Omaveloxolone Avapritinib Ayvakit Reduced CYP3A4 substrate exposure and reduced efficacy of CYP3A4 substrate Details Omaveloxolone Avatrombopag Doptelet Reduced CYP3A4 substrate exposure and reduced efficacy of CYP3A4 substrate Details Omaveloxolone Belumosudil Rezurock Explained Reduced CYP3A4 substrate exposure and reduced efficacy of CYP3A4 substrate Details Omaveloxolone Atorvastatin Atorvaliq Reduced CYP3A4 substrate exposure and reduced efficacy of CYP3A4 substrate Details Omaveloxolone Cariprazine Vraylar Explained Effects on the cariprazine exposure has not been evaluated and the net effect is unclear Details Omaveloxolone Abiraterone Abirtega Reduced CYP3A4 substrate exposure and reduced efficacy of CYP3A4 substrate Details Omaveloxolone Aficamten Reduced CYP3A4 substrate exposure and reduced efficacy of CYP3A4 substrate Details Omaveloxolone Alfuzosin UroXatral Reduced CYP3A4 substrate exposure and reduced efficacy of CYP3A4 substrate Details Omaveloxolone Amlodipine Amvaz® Reduced CYP3A4 substrate exposure and reduced efficacy of CYP3A4 substrate Details Omaveloxolone Avanafil Stendra Reduced CYP3A4 substrate exposure and reduced efficacy of CYP3A4 substrate Details Omaveloxolone Axitinib Inlyta Reduced CYP3A4 substrate exposure and reduced efficacy of CYP3A4 substrate Details Omaveloxolone Bedaquiline Sirturo Reduced CYP3A4 substrate exposure and reduced efficacy of CYP3A4 substrate Details Omaveloxolone Bosutinib Bosulif Reduced CYP3A4 substrate exposure and reduced efficacy of CYP3A4 substrate Details Omaveloxolone Brexpiprazole Rexulti Reduced CYP3A4 substrate exposure and reduced efficacy of CYP3A4 substrate Details Omaveloxolone Brigatinib Alunbrig Reduced CYP3A4 substrate exposure and reduced efficacy of CYP3A4 substrate Details Omaveloxolone Budesonide Entocort Reduced CYP3A4 substrate exposure and reduced efficacy of CYP3A4 substrate Details Omaveloxolone Budesonide Nasal Spray Rhinocort Reduced CYP3A4 substrate exposure and reduced efficacy of CYP3A4 substrate Details Omaveloxolone Budesonide Oral Inhalation Pulmicort Reduced CYP3A4 substrate exposure and reduced efficacy of CYP3A4 substrate Details Omaveloxolone Cabozantinib Cabometyx Reduced CYP3A4 substrate exposure and reduced efficacy of CYP3A4 substrate Details Omaveloxolone Cabozantinib (Thyroid Cancer) Cabometyx Reduced CYP3A4 substrate exposure and reduced efficacy of CYP3A4 substrate Details Omaveloxolone Capmatinib Tabrecta Reduced CYP3A4 substrate exposure and reduced efficacy of CYP3A4 substrate Details Omaveloxolone Clindamycin Injection ANTIROBE Reduced CYP3A4 substrate exposure and reduced efficacy of CYP3A4 substrate Details Omaveloxolone Clindamycin Topical C/T/S® Reduced CYP3A4 substrate exposure and reduced efficacy of CYP3A4 substrate Details Omaveloxolone Clindamycin Vaginal Cleocin Reduced CYP3A4 substrate exposure and reduced efficacy of CYP3A4 substrate Details Omaveloxolone Cobimetinib Cotellic Reduced CYP3A4 substrate exposure and reduced efficacy of CYP3A4 substrate Details